According to the ‘Cosmo feminist’, Jill Filipovic – there are over 222 million around the world who would like to have families but who do not have access to contraception. There are 69 countries where this injectable birth control device (vaccine) will be available. However, it will not be available in the U.S. Why? Because it is covered by insurance? Healthcare policies? Or perhaps, because too many women – as indicated by a post on Depo withdrawal on my blog who are suffering from severe side effects and withdrawal coming down from the drug. And now it will be marketed to unsuspecting women around the world?
WARNING: LOSS OF BONE MINERAL DENSITY
Women who use Depo-Provera Contraceptive Injection may lose significant bone mineral density. Bone loss is greater with increasing duration of use and may not be completely reversible.
It is unknown if use of Depo-Provera Contraceptive Injection during adolescence or early adulthood, a critical period of bone accretion, will reduce peak bone mass and increase the risk for osteoporotic fracture in later life.
Depo-Provera Contraceptive Injection should not be used as a long-term birth control method (i.e., longer than 2 years) unless other birth control methods are considered inadequate. (See Warnings and Precautions (5.1)).
So maybe I missed the real reason why this $1 Depo birth control shot will be be marketed in the U.S. – it would never pass FDA approval. But then again…
Please read – and read again: Depo should not be used as a long-term birth control method – unless all other methods are ruled out. Women around the world will not have this option.
So the question begs to be asked. Is Depo being used on women around the world to prevent pregnancy until they are ready to have a family – or as a population control method? Gendercide? Sterilization?
$1 Birth Control Is on the Way
This simple injectable could save women’s lives across the globe
November 17, 2014
A new contraceptive method that costs just $1 means women all over the world now have more options in planning the number and spacing of their children. Under a new agreement between the Gates Foundation, the pharmaceutical company Pfizer, and the Children’s Investment Fund Foundation, women in 69 of the poorest countries across the globe will have access to the new injectable method, a thin needle attached to a squeezable plastic bubble full of the drug. The actual contraceptive drug is a lower dose of Depo-Provera, a common birth control method, and the delivery system, called Uniject, has also been used for immunizations.
It’s virtually fool-proof — the dosage is preset and there’s no need to fill a syringe, meaning dosing errors are eliminated, and the device cannot be reused, cutting down the risk of infection from needle-sharing. It’s an easy tool for health workers to use. And while some other contraceptive injections go into a patient’s leg or bottom, this one goes into the arm, which makes many women who are concerned about modesty and hesitant to lift their dresses for health care workers more likely to use it. Once injected, women are protected from unintended pregnancy for three months.